Next Article in Journal
Stability Indicating LC-Method for Estimation of Paracetamol and Lornoxicam in Combined Dosage Form
Previous Article in Journal
Optimization of Forced Degradation Using Experimental Design and Development of a Stability-Indicating Liquid Chromatographic Assay Method for Rebamipide in Bulk and Tablet Dosage Form
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development and Validation of a Stability Indicating RP-UPLC Method for Determination of Quetiapine in Pharmaceutical Dosage Form

1
Analytical Research and Development, Integrated Product Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad-500 072, India
2
P. S. Science and H. D. Patel Arts College, S. V. Campus, Kadi-382 715, Gujarat, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2011, 79(1), 97-112; https://doi.org/10.3797/scipharm.1009-12
Submission received: 25 September 2010 / Accepted: 16 January 2011 / Published: 16 January 2011

Abstract

The present work reports a stability indicating reversed phase ultra performance liquid chromatography (RP-UPLC) method for the quantitative determination of quetiapine in pharmaceutical dosage form. The chromatographic separation is performed on an Agilent Eclipse Plus C18, RRHD 1.8 μm (50 mm x 2.1 mm) column using gradient elution. The optimized mobile phase consists of 0.1 % aqueous triethylamine (pH 7.2) as a solvent-A and 80:20 v/v mixture of acetonitrile and methanol as solvent-B. The eluted compounds are monitored at 252 nm wavelength using a UV detector. The developed method separates quetiapine from its five impurities/degradation products within a run time of 5 min. Stability indicating capability of the developed method is established by analyzing forced degradation samples in which the spectral purity of quetiapine is ascertained along with the separation of degradation products from analyte peak. The developed RP-UPLC method is validated as per International Conference on Harmonization (ICH) guidelines with respect to system suitability, specificity, precision, accuracy, linearity, robustness and filter compatibility.
Keywords: Seroquel; Assay; Method validation; Degradation products; Rapid; Chromatography Seroquel; Assay; Method validation; Degradation products; Rapid; Chromatography

Share and Cite

MDPI and ACS Style

TRIVEDI, R.K.; PATEL, M.C. Development and Validation of a Stability Indicating RP-UPLC Method for Determination of Quetiapine in Pharmaceutical Dosage Form. Sci. Pharm. 2011, 79, 97-112. https://doi.org/10.3797/scipharm.1009-12

AMA Style

TRIVEDI RK, PATEL MC. Development and Validation of a Stability Indicating RP-UPLC Method for Determination of Quetiapine in Pharmaceutical Dosage Form. Scientia Pharmaceutica. 2011; 79(1):97-112. https://doi.org/10.3797/scipharm.1009-12

Chicago/Turabian Style

TRIVEDI, Rakshit Kanubhai, and Mukesh C. PATEL. 2011. "Development and Validation of a Stability Indicating RP-UPLC Method for Determination of Quetiapine in Pharmaceutical Dosage Form" Scientia Pharmaceutica 79, no. 1: 97-112. https://doi.org/10.3797/scipharm.1009-12

Article Metrics

Back to TopTop